LOINC
Version 2.73

63402-2Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by ImmunoassayActive

Part Description

LP16760-8   Sjogrens syndrome-A extractable nuclear
Sjogren syndrome type A antigen (also known as SS-A, Ro, and E3 ubiquitin-protein ligase TRIM21) and Sjogren syndrome type B antigen (also known as SS-B and Lupus La protein) are nuclear antigens to which autoantibodies develop in autoimmune disorders such as Sjogren's syndrome (SS) and systemic lupus erythematosus (SLE). Between 40 and 70% of patients with SS have anti-SSA and/or anti-SSB autoantibodies, and 30-40% and 10-15% of patients with SLE are anti-SSA and anti-SSB positive, respectively. Longitudinal studies have shown that anti-SSA and -SSB antibodies may be present up to 20 years before the clinical onset of disease. SS patients who are anti-SSA and anti-SSB positive may have longer disease duration, parotid gland enlargement, decreased salivary flow, more severe minor salivary gland infiltration and a higher prevalence of extraglandular manifestations. [PMID:27184054] Source: Regenstrief LOINC, PMID: 27184054

Fully-Specified Name

Component
Sjogrens syndrome-A extractable nuclear Ab
Property
PrThr
Time
Pt
System
CSF
Scale
Ord
Method
IA

Additional Names

Short Name
ENA SS-A Ab CSF Ql IA
Display Name
Sjogrens syndrome-A extractable nuclear Ab IA Ql (CSF)
Consumer Name Alpha
Sjogrens syndrome-A extractable nuclear antibody, Spinal fluid

Basic Attributes

Class
SERO
Type
Laboratory
First Released
Version 2.36
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Groups

LG29303-1 Sjogrens syndrome-A extractable nuclear Ab|PrThr|Pt|CSF

Language Variants Get Info

zh-CNChinese (China)
Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法
nl-NLDutch (Netherlands)
SS-A extraheerbare nucleaire As:aanwezigheid:moment:liquor cerebrospinalis:ordinaal:immunoassay
fr-BEFrench (Belgium)
Syndrome de Sjögren-a nucléaire soluble Ac:PrThr:Temps ponctuel:LCR:Ordinal:IA
fr-CAFrench (Canada)
Syndrome de Sjögren-a nucléaire soluble , Ac:Présence-Seuil:Temps ponctuel:LCR:Ordinal:IA
fr-FRFrench (France)
SSA/Ro anticorps:Présence/Seuil:Ponctuel:Liquide céphalorachidien:Qualitatif:Immunoanalyse
el-GRGreek (Greece)
Αντι-Ro (SSA) Αντίσωμα:PrThr:Χρονική στιγμή:ΕΝΥ:Τακτική:IA
it-ITItalian (Italy)
Sjogren, sindrome-nucleare estraibile A Ab:PrThr:Pt:LCS:Ord:IA
ru-RURussian (Russian Federation)
Шегрена синдром-A экстрагируемый ядерный Ат:PrThr:ТчкВрм:ЦСЖ:Пор:IA
es-MXSpanish (Mexico)
Síndrome de Sjogrens:Ab nuclear extraíble:Presencia o umbral:Punto temporal:Fluído espinal cerebral:Ordinal
es-ESSpanish (Spain)
Antígeno nuclear extraíble Síndrome de Sjogren-A (SS-A) Anticuerpos:PrThr:Punto temporal:Líquido Cefalorraquideo:Ord:IA
tr-TRTurkish (Turkey)
Sjögrens sendromu-A özütlenebilir nükleer Ab:MevcEşik:Zmlı:BOS:Srl:İA

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=63402-2